Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2,2-methylenebis(4-chloro-3-methyl-isopropylphenol)
1. 15686-33-6
2. 6,6'-methylenebis(4-chloro-2-isopropyl-5-methylphenol)
3. Biclotymol [inn:dcf]
4. 6,6'-dichlor-2,2'-methylendithymol
5. Hexaspray
6. 4-chloro-2-[(5-chloro-2-hydroxy-6-methyl-3-propan-2-ylphenyl)methyl]-3-methyl-6-propan-2-ylphenol
7. 2,2'-methylenebis(6-chlorothymole)
8. W4k0ae8xw9
9. Biclotymol (inn)
10. Biclotymolum
11. Biclotymol [inn]
12. Hexaspray (tn)
13. Biclotymolum [inn-latin]
14. Unii-w4k0ae8xw9
15. Einecs 239-771-5
16. Thymol, 2,2'-methylenebis[6-chloro-
17. Phenol, 2,2'-methylenebis[4-chloro-3-methyl-6-(1-methylethyl)-
18. Biclotymol [mart.]
19. Biclotymol [who-dd]
20. Schembl70634
21. Chembl2107655
22. Dtxsid90166144
23. Chebi:177790
24. Zinc4215009
25. Mfcd00865128
26. Ds-13173
27. Cs-0059759
28. D07527
29. W17157
30. 686b336
31. Q2901642
32. 2,2-methylenebis(4-chloro-3-methyl-isopropylphenol)
33. 4-chloro-2-[(5-chloro-2-hydroxy-3-isopropyl-6-methyl-phenyl)methyl]-6-isopropyl-3-methyl-phenol
| Molecular Weight | 381.3 g/mol |
|---|---|
| Molecular Formula | C21H26Cl2O2 |
| XLogP3 | 7.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 4 |
| Exact Mass | 380.1309855 g/mol |
| Monoisotopic Mass | 380.1309855 g/mol |
| Topological Polar Surface Area | 40.5 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 390 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Biclotymol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Biclotymol, including repackagers and relabelers. The FDA regulates Biclotymol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Biclotymol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Biclotymol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Biclotymol supplier is an individual or a company that provides Biclotymol active pharmaceutical ingredient (API) or Biclotymol finished formulations upon request. The Biclotymol suppliers may include Biclotymol API manufacturers, exporters, distributors and traders.
click here to find a list of Biclotymol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Biclotymol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Biclotymol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Biclotymol GMP manufacturer or Biclotymol GMP API supplier for your needs.
A Biclotymol CoA (Certificate of Analysis) is a formal document that attests to Biclotymol's compliance with Biclotymol specifications and serves as a tool for batch-level quality control.
Biclotymol CoA mostly includes findings from lab analyses of a specific batch. For each Biclotymol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Biclotymol may be tested according to a variety of international standards, such as European Pharmacopoeia (Biclotymol EP), Biclotymol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Biclotymol USP).
LOOKING FOR A SUPPLIER?
